Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1. J Virol Methods, 163: 505-508 (2010).

Publication Latest Publications

Title: Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1
Authors: Wallis CL, Papathanasopoulos MA, Lakhi S, Karita E, Kamali A, Kaleebu P, Sanders E, Anzala O, Bekker LG, Stevens G, De Wit TF, Stevens W .
Journal: J Virol Methods,163:505-508 (2010)

Journal Impact Factor (I.F.): 2.065
Number of citations (Google Scholar): 31

Abstract

Download: Full text paper

Citation: Wallis CL, Papathanasopoulos MA, Lakhi S, Karita E, Kamali A, Kaleebu P, Sanders E, Anzala O, Bekker LG, Stevens G, De Wit TF, Stevens W . Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1 J Virol Methods,163:505-508 (2010).


Impact of point-of-care Xpert MTB/RIF on tuberculosis treatment initiation: a cluster randomised trial
Journal: Am J Respir Crit Care Med (2017)

Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele
Journal: Pharmacogenomics and Personalized Medicine (2017)

Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa
Journal: Journal of Antimicrobial Chemotherapy (2017)
All publications...


Page design updated by Tulio de Oliveira, 2013